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Breast cancer-related lymphedema (BCRL) is a complication of breast cancer (BrCa) treatment that affects 6%Y70% of BrCa survivors. 1, 2 BCRL is an incurable, lifelong condition characterized by accumulation of protein-rich fluid that manifests as swelling of the upper limb and causes discomfort, altered physical function, and impaired quality-of-life. 2, 3 The chronic, cyclic clinical sequence of BCRL forces BrCa survivors to allocate a considerable amount of time to manage BCRL. 4 Among 39 BrCa survivors in a cross-sectional survey, 66% reported spending greater than or equal to 150 minIwk j1 on BCRL self-care activities. 5 In this same survey, women reported a number of barriers and burdens to BCRL self-care including lack of time and convenience, high cost, lack of results, and aggravation. 5 Corroborating these findings, among 141 BrCa survivors, 41% reported BCRL self-care adherence of less than 50% of levels prescribed by their lymphedema therapists. 6 Weight-lifting exercise has emerged as an efficacious modality to improve BCRL outcomes among BrCa survivors. This addition of weight lifting to the armamentarium of BCRL prevention and management has challenged previous beliefs that weight lifting was detrimental to BCRL outcomes. 7 The rapidly increasing number of modalities available for BCRL management has prompted the need to empirically review the evidence relating to BCRL management. Two recent reviews that included more than 3200 BrCa survivors, 8, 9 and the advisory committee for Centers for Medicare and Medicaid Services, 10 concluded that, despite widespread use, the depth, breadth, and quality of literature supporting BCRL management is scant, and subsequent studies should focus on strengthening the evidence to provide efficacious modalities to BrCa survivors to manage BCRL.
This study sought to deepen the understanding of the relationship between BCRL self-care adherence and BCRL outcomes by exploring the hypothesis that adherence to BCRL self-care activities predicts BCRL outcomes among BrCa survivors who entered 12 mos of follow-up with stable lymphedema. The authors hypothesized that higher levels of BCRL self-care adherence would predict a reduction in the likelihood of experiencing a BCRL outcome, relative to low levels of BCRL self-care adherence.
METHODS

Participants
Participants were enrolled in the physical activity and lymphedema (PAL) trial, a randomized controlled trial to examine the safety of progressive weight lifting among women with BCRL. The Social Cognitive Theory formed the theoretical basis for the PAL intervention. 11 A detailed account of the PAL study has been published elsewhere. 11 In short, participants were randomized to either a progressive weight-lifting intervention or no exercise. Eligibility criteria included (1) female BrCa survivor of 1Y15 yrs postdiagnosis, (2) free from cancer at study entry, (3) one or more lymph nodes removed, and (4) no medical conditions or contraindicated medications that would prohibit participation in an exercise program. Additional criteria included (5) body mass index of 50 kg/m 2 or less, (6) no plans for surgery during the intervention period, (7) no history of bilateral lymph node dissection, (8) no weight lifting in the previous year, and (9) stable body weight and not attempting to lose weight.
A participant was considered to have BCRL at study entry if she had one or more of the following: (1) 10% or greater interlimb discrepancy in total arm volume, (2) meeting any of the Common Toxicity Criteria Adverse Event version 3.0 for BCRL (swelling, obscuration, or pitting), 12 or (3) previous clinical diagnosis of BCRL that was confirmed by study measurements or by a therapist. In the event that a participant reported having BCRL that was not evident at study entry, she was required to provide written documentation of a previous diagnosis of BCRL from her lymphedema therapist. All study participants were required to have a stable BCRL at study entry, defined as absence of all of the following 3 mos before enrolling in the study: (1) receiving complete decongestive therapy, (2) self-reporting a 10% or greater change in arm volume or circumference that lasted 1 wk or longer, (3) having a BCRL-related infection that required the use of antibiotics, or (4) experiencing a change in activities of daily living because of a BCRL exacerbation. This study was approved by the institutional review board of the University of Pennsylvania. Participants provided written informed consent and written clearance from their physicians.
BCRL Outcome Variables
Measurements were obtained for all study participants at baseline and 12 mos by blinded measurement staff. The five BCRL outcomes for this exploratory analysis were (1) volumetry, 13, 14 (2) arm circumferences, 14 (3) bioimpedence spectroscopy, 15, 16 (4) the Norman lymphedema survey, 17 and lymphedema exacerbation requiring treatment. 11, 12 Volumetric measures were obtained by submerging the arm and hand in water and using the displaced water volume to determine limb volume. If the volume of the treated side was 10% greater than that of the untreated side, the participant was deemed to have clinically evident BCRL. Volumetry is correlated with circumference measures (r = 0.90, P G 0.0001) 13 and is reliably measured (intraclass correlation, 0.99). 14 Circumference measures were taken at the metacarpal and wrist and every 4 cm along the arm until the axillary fold. The authors used arm circumferences to calculate two outcomes: (1) the sum of arm circumferences 18 and (2) the arm volume using the truncated cone method. 19 If the sum (or volume) of the arm circumferences for the treated side was 10% greater than the sum of the arm circumferences for the untreated side, the participant was considered to have clinically evident BCRL. In the PAL cohort, water displacement volumetry was strongly correlated with arm volume circumferences calculated using the truncated cone method (r = 0.960, P G 0.0001). Consequentially, the statistical analysis of circumference-calculated arm volume was similar to that of water displacement volumetry (data not shown). Bioimpedence spectroscopy was used to measure the impedance of extracellular fluid of each arm. The impedance of the treated and untreated arms was compared. If the ratio of measurements exceeded normative values, BCRL was deemed to be clinically evident. 18 Bioimpedence spectroscopy is correlated with deuterium-isotope dilution (r = 0.986, P G 0.001), the gold-standard method to quantify total body water. 16 Participants were asked to complete the Norman lymphedema survey, which evaluated the frequency and severity of 14 BCRL-related symptoms. 17 The Norman lymphedema survey correctly classifies 84%Y88% of women with therapistdiagnosed lymphedema and has high agreement across therapists (J = 0.80). 17 After randomization into the study, participants were evaluated for a possible BCRL exacerbation that required treatment if they reported a change in symptoms that lasted 1 wk or longer or measurements indicated an increase of 5% or greater in interlimb discrepancy, accompanied by an increase of 5% or greater in the affected arm, as compared with the previous measurement time point. Exacerbations were diagnosed by the evaluating lymphedema therapist, based on clinical evaluation of tissue tone, texture, and color as well as swelling and symptom changes in accordance with the Common Toxicity Criteria Adverse Event version 3.0 for BCRL. 12
BCRL Self-Care Adherence Questionnaire
Study investigators with training in physical medicine and rehabilitation, BCRL self-care and clinical treatment, and survey design developed a questionnaire that assessed use and adherence to ten BCRL self-care modalities, 6 as recommended in the 2001 clinical practice guidelines for the treatment and care of BCRL. 4 After receiving feedback from other investigators in the area of BCRL, this questionnaire was implemented in the PAL trial. Modalities in the questionnaire included physical therapy exercise, pneumatic compression pump, medication (i.e., benzopyrones), lymphedema bandaging, arm elevation, self-administered lymphatic drainage, therapist-administered lymphatic drainage, compression garment, skin care, taping, or other modalities not listed. In 2009, the clinical practice guidelines for the care of BCRL were revised, given evidence supporting the association of benzopyrones with liver toxicity. 20 BCRL self-care adherence was defined as the proportion of the current frequency of use relative to the prescribed frequency of use. 6 If a participant responded yes to having been prescribed one or more of the self-care modalities, she was further questioned about her adherence to each self-care modality. 6 A multiple-choice response was provided for adherence to each BCRL self-care modality with four possible responses: (1) less than 25% of the time, (2) 25%Y49% of the time, (3) 50%Y74% of the time, or (4) 75%Y100% of the time, as recommended by their lymphedema therapist. The authors generated a composite adherence score for each participant based on the BCRL self-care modalities reported at study entry, using the adherence categories described previously (G25%, 25%Y49%, 50%Y74%, or 75%Y100%). Mean adherence equally weighted each BCRL self-care modality prescribed to a participant. This weighting approach implies equal importance of adherence across all prescribed BCRL self-care modalities (i.e., that one modality is not more important to adhere to than another). The authors elected to use an equal weighting approach given the paucity of data to support the proportional importance of individual BCRL self-care modalities in relation to one another. 4, 21 They have previously reported that, during the 12-mo study, the total number of BCRL self-care modalities did not change and the composite adherence to BCRL self-care modalities did not change. 6 Therefore, this analysis used baseline BCRL self-care adherence (other analysis methods did not change the results presented herein; data not shown).
Cancer staging was taken from state cancer registries, surgical pathology reports, or self-report. The number of lymph nodes removed was obtained from surgical pathology reports. Body mass index was calculated using objectively measured height and weight. These variables were collected at baseline.
Statistical Analysis
Descriptive statistics for BCRL outcome variables include counts and percentages for binary variables and means and standard deviations or medians and interquartile ranges for continuous variables. Generalized linear models were used to estimate risk ratios for categorical variables. P values from the test for trend (P trend ) were calculated using BCRL self-care adherence as a continuous variable in the regression models. BCRL outcomes (i.e., volumetry, circumference measures, etc.) were also examined as continuous variables in a multivariable-adjusted sensitivity analysis. Hand dominance may influence measurement and diagnostic precision of lymphedema outcomes 22 ; therefore, the authors adjusted for dominance in their statistical analysis. In post hoc power calculations, the authors had 80% or greater statistical power to detect a significant test for trend for the continuous variable outcomes. The nature of this study was exploratory rather than confirmatory with respect to statistical hypothesis testing. Stata v.12/SE was used for all statistical analyses.
RESULTS
Participant Characteristics
The PAL trial recruited 141 women with BRCL to assess the effects of a slowly progressive weightlifting program on lymphedema outcomes. Two women were excluded from this analysis because of a second primary or recurrent cancer. Eleven women were excluded from this analysis because they reported being prescribed no BCRL self-care modalities and thus provided no information on BCRL self-care adherence. The 128 participants included in this analysis were aged 37Y80 yrs at baseline and had a variety of educational, racial, and occupational backgrounds (see Table 1 ). Time since BrCa diagnosis ranged from 14 to 183 mos, and the number of lymph nodes removed ranged from 1 to 38. Time since lymphedema diagnosis ranged from 1 to 183 mos. Baseline BCRL outcome measures are presented in Table 2 .
Lymphedema Self-Care Adherence and Lymphedema Outcomes Use of individual BCRL self-care modalities has been reported elsewhere in detail. 6 In short, the most commonly used BCRL self-care modalities included compression garments (79%), bandaging (68%), exercise (58%), elevation (42%), therapistadministered lymphatic drainage (46%), selfadministered lymphatic drainage (39%), and skin care (33%). The least commonly used BCRL selfcare modalities included pneumatic compression pumps (12%), taping (8%), and medications (5%). Collectively, BCRL self-care adherence among the 128 women prescribed with one or more lymphedema self-care modality was as follows: 16 (13%) reported a mean of less than 25% of adherence, 36 (28%) reported a mean of 25%Y49% of adherence, 40 (31%) reported a mean of 50%Y74% of adherence, and 36 (28%) reported a mean of 75%Y100% of adherence.
Using generalized linear regression models, higher levels of adherence to BCRL self-care activities did not predict BCRL outcomes (see Table 3 ). When BCRL outcomes were examined as continuous variables in a multivariable-adjusted sensitivity analysis (adjusted for factors listed in Table 1 in addition to hand dominance and randomized group assignment), adherence to BCRL self-care activities did not predict changes in volumetry (G25% compared with Q75% of adherence, A = 0.09 and P trend = 0.741), sum of arm circumferences (G25% compared with Q75% of adherence, A = j0.63 and P trend = 0.693), bioimpedence spectroscopy (G25% compared with Q75% of adherence, A = 4.04 and P trend = 0.753), or lymphedema symptoms (G25% compared with Q75% adherence, A = j0.14 and P trend = 0.306). Lymphedema exacerbation was a binary variable and, subsequently, was not included in the continuous variable sensitivity analyses.
DISCUSSION
The major finding of this study is that levels of BCRL self-care adherence did not predict BCRL outcomes during 12 mos. Adherence to BCRL self-care activities has been noted as an impediment to the long-term success of BCRL treatment. 4 In the study sample, among BrCa survivors with stable lymphedema, the authors were unable to identify an association between adherence to BCRL self-care modalities and a variety of BCRL outcomes during 12 mos.
Although this analysis begins to shed light on the efficacy of BCRL self-care, there are several important limitations that influence the interpretation of this study's exploratory findings. The first limitation is that this was a secondary analysis of the PAL trial. The PAL trial had a variety of inclusion and exclusion criteria regarding BCRL, 11 such as stability of BCRL before entering the study. Furthermore, the time since BCRL diagnosis varied from 1 to 183 mos, and time since last lymphedema treatment varied from 3 to 120 mos at study entry. Therefore, BrCa survivors for whom BCRL frequently fluctuated or required intensive therapy were not included in the PAL trial. Despite this criterion, 16 participants (12%) experienced a 5% or greater increase in interlimb arm volume difference, 28 participants (22%) experienced a 5% or greater decrease in interlimb arm volume difference, and 28 participants (22%) required complete decongestive therapy during the 12-mo intervention. 7 The PAL study was a yearlong weight-lifting exercise trial. Women who did not have sufficient time to participate or did not have interest in enrolling in an exercise study were also excluded. Therefore, the generalizability of the study findings is limited to BrCa survivors similar to those in the PAL trial. The analysis of the authors' questionnaire was not weighted, such that all BCRL self-care modalities were given equal importance. The authors elected to use this nonweighted approach on the basis that, if a combination of BCRL self-care modalities was recommended to a specific participant, then the adherence to all of the self-care modalities in that combination was equally important, as part of a comprehensive BCRL self-care program. There are no data to inform how weights would be assigned to each self-care modality and the relative impact that weighting of BCRL self-care modalities has on lymphedema outcomes. There exists the possibility of recall bias because of the selfreport nature of the authors' questionnaire. Participants may have forgotten that their lymphedema therapist prescribed certain BCRL self-care modalities that may result in underreporting. Furthermore, participants may have also forgotten the frequency in which their lymphedema therapist recommended certain BCRL self-care activities to be undertaken. All participants were required to attend a 1-hr educational lecture entitled the BLymphedema Education Session[ that was based on material from the National Lymphedema Network. This educational session was taught by the PAL principal investigator (Schmitz) to ensure that all participants had a comparable understanding of lymphedema self-care methods while in the PAL trial. However, the authors did not collect information that allowed them to quantify the level of BCRL self-care education or skill in completing the prescribed BCRL self-care activities. Therefore, the authors' null findings may reflect poor or inappropriate use of the prescribed modalities because of insufficient patient education, rather than poor subject adherence to the BCRL selfcare modalities. Additional limitations to the exploratory analysis include the limited number of observed outcomes. The small sample size of outcomes precluded the examination of adherence to individual BCRL modalities and BCRL outcomes. The small sample size also precluded the exploration of specific demographic and clinical subgroups. When the authors conducted sensitivity analyses treating the outcome variables (i.e., volumetry, circumference measures, etc.) as continuous measures in multivariable-adjusted regression models, their results were similar to one another. Adjustment for randomized group assignment did not influence the study findings. The authors' previous report demonstrated that randomized group did not influence BCRL self-care practices during the 12-mo study. 6 The ability for those with BCRL to adequately adhere to BCRL self-care has been a concern for more than a decade. 21 A previous study determined that noncompliance with BCRL bandaging and compression garment use were risk factors for increased arm volume 1 yr after receiving complete decongestive therapy. 23 Poor BCRL self-care compliance to phase II decongestive activities after receiving phase I complete decongestive therapy has resulted in failure rates of 38%, 53%, and 65% at 1, 2, and 4 yrs, respectively. 24 Restricting the authors' analyses to only include phase II complete decongestive activities, their conclusions did not change. Nonetheless, these data suggest that new strategies and methods to maintain arm health are needed among BrCa survivors with BCRL. 25 The PAL trial demonstrated that twice-weekly weight lifting reduced the need for therapist-defined BCRL treatment by 53% (P = 0.04). 7 Participants in the PAL trial were required to wear a well-fitting, study-provided compression garment during all weight-lifting activities. The physiologic underpinning of the PAL trial was that slowly progressive weight lifting improves flow of lymphatic fluid. 7 Indeed, there is evidence that exercise improves flow of lymphatic fluid by changes in sympathetic outflow, muscular constriction, diaphragmatic movement with physical exertion and increased breathing, and possibly, lymphangiogenesis and recruitment of dormant lymphatic vessels. 26 A previous study that examined isometric handgrip exercise among BrCa survivors who were not wearing compression sleeves con-cluded that lymphatic flow did not improve 5Y6 hrs after exercise. 27 It has been hypothesized that isotonic weight-lifting exercise coupled with a well-fitting compression garment may be effective in moving lymphatic fluid out of the arm, whereas weight lifting without adequate compression may be insufficient. 26 In the PAL trial, participants completed twice-weekly weight lifting. It is plausible that twice-weekly weight lifting is sufficient to improve lymphedema outcomes despite nonoptimal adherence to other BCRL selfcare modalities. 6 This evidence may suggest that a Data were reported by patients regarding 14 symptoms: rings too tight, watch too tight, bracelets too tight, clothing too tight, puffiness, knuckles not visible, veins not visible, skin feels leathery, arm feels tired, pain, pitting, swelling after exercise, difficulty writing, or other. The change in severity of symptoms is the mean of the changes in severity for all 14 symptoms, with the possible severity score for each ranging from 0 (no symptom) to 4 (very severe).
CI, confidence interval.
twice-weekly weight lifting coupled with a compression garment may be superior to daily self-care activities alone to improve BCRL outcomes. However, this hypothesis would need to be tested in a randomized controlled trial to provide definitive evidence. Most BrCa survivors (66%) spend greater than or equal to 150 minIwk j1 engaging in BCRL self-care activities. 5 Interestingly, weight lifting, such as that prescribed in the PAL trial, requires a similar amount of time (120Y180 minIwk j1 ) but is performed twice weekly rather than daily. 7, 11 The twice-weekly schedule of weight lifting might serve to reduce burden among those with BCRL and to help improve longterm compliance. In the PAL trial, the mean adherence to supervised weight lifting was 92% in 1Y6 mos and to unsupervised weight lifting was 78% in 6Y12 mos; these levels of adherence exceed those for individual BCRL self-care activities. 5Y7 In addition to reducing the likelihood for lymphedema treatment and reducing self-reported BCRL symptom severity, weight lifting improves muscular strength and body composition, 7 bone health, 28 and quality-of-life 29 among BrCa survivors. Thus, weight lifting may be a time-efficient multidimensional intervention to promote the health and longevity of BrCa survivors with BCRL. 25 In this study, increasing levels of BCRL self-care adherence did not predict BCRL outcomes among BrCa survivors with stable BCRL during 1 yr. These findings will need to be replicated in a separate cohort of BrCa survivors. The current hypothesis is that weight lifting with a well-fitting compression garment may serve as an efficacious modality to manage BCRL, while providing a multitude of other known health benefits to those with BrCa, compared with BCRL self-care alone. However, this hypothesis needs to be examined in a randomized controlled trial. Such a trial would provide definitive evidence of the efficacy of BCRL self-care vs. weight lifting.
